ERBB2 and neoplasm: To investigate the cause of the tumor regrowth observed after Day 46 in mice treated with an efficacious dose of RG7116 (1 mg/kg qw; Fig. 3b), mRNA and protein levels of HER1 and HER2 were examined in a separate study.